Cocrystal Pharma Inc. (COCP)
Cocrystal Pharma Statistics
Share Statistics
Cocrystal Pharma has 10.17M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 10.17M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 13.85% |
| Shares Floating | 6.95M |
| Failed to Deliver (FTD) Shares | 36 |
| FTD / Avg. Volume | 0.16% |
Short Selling Information
The latest short interest is 16.08K, so 0.16% of the outstanding shares have been sold short.
| Short Interest | 16.08K |
| Short % of Shares Out | 0.16% |
| Short % of Float | 0.23% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -1.17 and the forward PE ratio is -0.52. Cocrystal Pharma's PEG ratio is 0.
| PE Ratio | -1.17 |
| Forward PE | -0.52 |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 2.16 |
| P/FCF Ratio | -1.25 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Cocrystal Pharma.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.77, with a Debt / Equity ratio of 0.19.
| Current Ratio | 4.77 |
| Quick Ratio | 4.77 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | -0.1 |
| Debt / FCF | -0.11 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-1.59M |
| Employee Count | 11 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -8.22% in the last 52 weeks. The beta is 2.21, so Cocrystal Pharma's price volatility has been higher than the market average.
| Beta | 2.21 |
| 52-Week Price Change | -8.22% |
| 50-Day Moving Average | 1.65 |
| 200-Day Moving Average | 1.91 |
| Relative Strength Index (RSI) | 40.61 |
| Average Volume (20 Days) | 23.13K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -17.88M |
| Net Income | -17.5M |
| EBITDA | -17.88M |
| EBIT | -17.88M |
| Earnings Per Share (EPS) | -1.72 |
Balance Sheet
The company has 9.86M in cash and 1.81M in debt, giving a net cash position of 8.05M.
| Cash & Cash Equivalents | 9.86M |
| Total Debt | 1.81M |
| Net Cash | 8.05M |
| Retained Earnings | -333.42M |
| Total Assets | 13.46M |
| Working Capital | 9.15M |
Cash Flow
In the last 12 months, operating cash flow was -16.48M and capital expenditures -8K, giving a free cash flow of -16.49M.
| Operating Cash Flow | -16.48M |
| Capital Expenditures | -8K |
| Free Cash Flow | -16.49M |
| FCF Per Share | -1.62 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
COCP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for COCP is $7, which is 422.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $7 |
| Price Target Difference | 422.4% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Oct 11, 2022. It was a backward split with a ratio of 1:12.
| Last Split Date | Oct 11, 2022 |
| Split Type | backward |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | -36.19 |
| Piotroski F-Score | 1 |